Precipio (PRPO) News Today $6.50 -0.12 (-1.81%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$6.40▼$6.5050-Day Range$5.74▼$8.5552-Week Range$4.75▼$20.48Volume1,767 shsAverage Volume5,443 shsMarket Capitalization$9.23 millionP/E RatioN/ADividend YieldN/APrice Target$40.00 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePrecipio (NASDAQ:PRPO) Share Price Crosses Below Two Hundred Day Moving Average of $7.82americanbankingnews.com - November 29 at 3:40 AMmarketbeat.com - November 14 at 11:10 AMPrecipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022finance.yahoo.com - October 18 at 9:36 AMPrecipio, Inc.: Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023finanznachrichten.de - October 3 at 1:42 PMPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023finance.yahoo.com - October 3 at 1:42 PMPrecipio Continues to Sign New HemeScreen™ Customersfinance.yahoo.com - September 28 at 2:36 PMPrecipio Reduces Product Revenue Result Needed for Cash Flow Breakevenfinance.yahoo.com - September 25 at 3:15 PMPrecipio, Inc.: Precipio Takes Final Step Towards Regaining Nasdaq Compliancefinanznachrichten.de - September 22 at 10:32 AMPrecipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Planfinance.yahoo.com - September 13 at 7:15 PMBroker Revenue Forecasts For Precipio, Inc. (NASDAQ:PRPO) Are Surging Higherfinance.yahoo.com - August 20 at 5:26 PMPrecipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 19 at 6:59 AMPrecipio's Earnings: A Previewbenzinga.com - August 16 at 4:17 PMPrecipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Storyfinance.yahoo.com - August 13 at 6:38 PMPrecipio Announces Q2-2023 Shareholder Update Callfinance.yahoo.com - August 11 at 3:14 AMPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panelfinance.yahoo.com - August 8 at 11:07 AMPrecipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakevenfinance.yahoo.com - August 3 at 1:39 PMEnd in sight for U.S. insider trading case over healthcare leaksinvesting.com - August 1 at 5:31 PMPrecipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023finance.yahoo.com - August 1 at 5:31 PMPrecipio (PRPO) Price Target Decreased by 29.82% to 2.04msn.com - July 6 at 1:54 PMPrecipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technologyfinance.yahoo.com - June 13 at 5:39 PMWhy Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionmsn.com - June 8 at 4:34 PMPrecipio Shares Slide Premarket on Sale of Equities >PRPOmarketwatch.com - June 8 at 10:15 AMPrecipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placementfinance.yahoo.com - June 8 at 10:15 AMProjected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projectsfinance.yahoo.com - June 7 at 1:40 PMPrecipio GAAP EPS of -$0.13 misses by $0.02, revenue of $2.82M beats by $0.02Mmsn.com - May 17 at 9:26 PMPrecipio Shares Growth Catalysts For HemeScreenfinance.yahoo.com - May 17 at 4:25 PMPrecipio Announces Q1-2023 Shareholder Update Callfinance.yahoo.com - May 15 at 6:12 PMPrecipio Signs Another HemeScreen™ Customerfinance.yahoo.com - May 4 at 4:53 PMPrecipio Adds Substantial Pathology Customer to its Diagnostic Services Divisionfinance.yahoo.com - May 4 at 4:53 PMPrecipio Granted 180-day Extension From NASDAQ To Regain Compliancefinance.yahoo.com - April 27 at 7:03 PMPrecipio, Inc.: Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combinedfinanznachrichten.de - April 20 at 10:58 AMPrecipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combinedfinance.yahoo.com - April 19 at 1:14 PMPrecipio, Inc. (NASDAQ:PRPO) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - April 9 at 12:33 PMPrecipio Full Year 2022 Earnings: US$0.54 loss per share (vs US$0.40 loss in FY 2021)finance.yahoo.com - April 2 at 2:15 PMPrecipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Callbenzinga.com - March 28 at 9:04 PMPrecipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Callfinance.yahoo.com - March 28 at 9:04 PMPrecipio Ships First IV-Cell® Order to Major US Healthcare Systemfinance.yahoo.com - March 21 at 12:39 PMPrecipio continues to sign up and onboard HemeScreen™ customersfinance.yahoo.com - March 7 at 5:26 PMCORRECTION -- Precipio continues to sign up and onboard HemeScreen™ customersfinance.yahoo.com - March 7 at 5:26 PMThermoFisher Salesforce Votes Precipio’s HemeScreen® as “Best New Product”finance.yahoo.com - February 14 at 3:30 PMPrecipio Signs Another Major HemeScreen™ Customerfinance.yahoo.com - January 11 at 1:51 PMPrecipio Signs Additional Major HemeScreen™ Customerfinance.yahoo.com - December 6 at 4:32 PMPrecipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conferencefinance.yahoo.com - November 7 at 4:25 PMPrecipio Announces Third Quarter Shareholder Update Callfinance.yahoo.com - November 2 at 6:51 PMRedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Yahoo Financefinance.yahoo.com - October 18 at 3:25 PMPrecipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Futurefinance.yahoo.com - October 18 at 10:24 AMMedical Device and Diagnostic Reimbursements Expert Joins NDA Partners as Expert Consultant - Yahoo Financefinance.yahoo.com - October 7 at 5:55 PMPrecipio And 2 Other Penny Stocks Insiders Are Aggressively Buying - Liberty Star Uranium (OTC:LBSR), Cle - Benzingabenzinga.com - October 7 at 12:55 PMPoint of Care (PoC) Infectious Disease Testing Market Surging Over 4X Touching USD 4.22 Billion by 2028 | BlueWeave Consulting - Yahoo Financefinance.yahoo.com - September 17 at 9:17 PMPoint of Care (PoC) Infectious Disease Testing Market Surging Over 4X Touching USD 4.22 Billion by 2028 | BlueWeave Consulting - GlobeNewswireglobenewswire.com - September 17 at 11:08 AM Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address PRPO Media Mentions By Week PRPO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRPO News Sentiment▼0.000.51▲Average Medical News Sentiment PRPO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRPO Articles This Week▼00▲PRPO Articles Average Week Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Telesis Bio News Talis Biomedical News Singular Genomics Systems News BIMI International Medical News BioRestorative Therapies News Edesa Biotech News NightHawk Biosciences News PetVivo News Tenax Therapeutics News XWELL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:PRPO) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.